Cargando…
Recombinase-Mediated Reprogramming and Dystrophin Gene Addition in mdx Mouse Induced Pluripotent Stem Cells
A cell therapy strategy utilizing genetically-corrected induced pluripotent stem cells (iPSC) may be an attractive approach for genetic disorders such as muscular dystrophies. Methods for genetic engineering of iPSC that emphasize precision and minimize random integration would be beneficial. We dem...
Autores principales: | Zhao, Chunli, Farruggio, Alfonso P., Bjornson, Christopher R. R., Chavez, Christopher L., Geisinger, Jonathan M., Neal, Tawny L., Karow, Marisa, Calos, Michele P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4004573/ https://www.ncbi.nlm.nih.gov/pubmed/24781921 http://dx.doi.org/10.1371/journal.pone.0096279 |
Ejemplares similares
-
Serine integrase chimeras with activity in E. coli and HeLa cells
por: Farruggio, Alfonso P., et al.
Publicado: (2014) -
Characterization of brain dystrophins absence and impact in dystrophin-deficient Dmd(mdx) rat model
por: Caudal, Dorian, et al.
Publicado: (2020) -
Sildenafil ameliorates cardiomyopathy in dystrophin-null (mdx) mice
por: Parchen, Candace M, et al.
Publicado: (2009) -
Increased Neointimal Thickening in Dystrophin-Deficient mdx Mice
por: Rauch, Uwe, et al.
Publicado: (2012) -
DICE, an efficient system for iterative genomic editing in human pluripotent stem cells
por: Zhu, Fangfang, et al.
Publicado: (2014)